BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37986213)

  • 1. Meta-analysis: Impact of intragastric balloon therapy on NAFLD-related parameters in patients with obesity.
    Aoko O; Maharaj T; Boland F; Cheriyan D; Ryan J
    Aliment Pharmacol Ther; 2024 Jan; 59(1):8-22. PubMed ID: 37986213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Intragastric Balloon (IGB) in Non-alcoholic Fatty Liver Disease (NAFLD): a Comprehensive Review and Meta-analysis.
    Chandan S; Mohan BP; Khan SR; Facciorusso A; Ramai D; Kassab LL; Bhogal N; Asokkumar R; Lopez-Nava G; McDonough S; Adler DG
    Obes Surg; 2021 Mar; 31(3):1271-1279. PubMed ID: 33409973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Intragastric Balloons on Liver Enzymes: A Systematic Review and Meta-Analysis.
    Popov VB; Thompson CC; Kumar N; Ciarleglio MM; Deng Y; Laine L
    Dig Dis Sci; 2016 Sep; 61(9):2477-87. PubMed ID: 27207181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intragastric Balloon Placement Induces Significant Metabolic and Histologic Improvement in Patients With Nonalcoholic Steatohepatitis.
    Bazerbachi F; Vargas EJ; Rizk M; Maselli DB; Mounajjed T; Venkatesh SK; Watt KD; Port JD; Basu R; Acosta A; Hanouneh I; Gara N; Shah M; Mundi M; Clark M; Grothe K; Storm AC; Levy MJ; Abu Dayyeh BK
    Clin Gastroenterol Hepatol; 2021 Jan; 19(1):146-154.e4. PubMed ID: 32360804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bariatric and metabolic endoscopy in the handling of fatty liver disease. A new emerging approach?
    Espinet Coll E; Vila Lolo C; Díaz Galán P; Gómez Valero JA; Bacchiddu S; Quintana Tomás C; Irigoyen D; Gunnard K; Juan-Creix Comamala A
    Rev Esp Enferm Dig; 2019 Apr; 111(4):283-293. PubMed ID: 30896957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intragastric Balloon Treatment for Obesity: Review of Recent Studies.
    Tate CM; Geliebter A
    Adv Ther; 2017 Aug; 34(8):1859-1875. PubMed ID: 28707286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intragastric balloon in patients with nonalcoholic fatty liver disease and advanced fibrosis.
    Salomone F; Currenti W; Magrì G; Boškoski I; Zelber-Sagi S; Galvano F
    Liver Int; 2021 Sep; 41(9):2112-2116. PubMed ID: 33938630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre.
    Nguyen V; Li J; Gan J; Cordero P; Ray S; Solis-Cuevas A; Khatib M; Oben JA
    Can J Gastroenterol Hepatol; 2017; 2017():4697194. PubMed ID: 29441342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Jirapinyo P; McCarty TR; Dolan RD; Shah R; Thompson CC
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):511-524.e1. PubMed ID: 33727164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic Bariatric Interventions in Patients with Chronic Liver Disease.
    Bustamante-Bernal MA; Chavez LO; Zuckerman MJ
    Clin Liver Dis; 2022 Feb; 26(1):139-148. PubMed ID: 34802660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Age, Gender, and Baseline BMI on Weight Loss Outcomes in Obese Patients Undergoing Intragastric Balloon Therapy.
    Diab AF; Abdurasul EM; Diab FH
    Obes Surg; 2019 Nov; 29(11):3542-3546. PubMed ID: 31267474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological Aspects of Treatment with Intragastric Balloon for Management of Obesity: A Systematic Review of the Literature.
    Pietrabissa G; Bertuzzi V; Simpson S; Guerrini Usubini A; Cattivelli R; Bertoli S; Mozzi E; Roviaro G; Castelnuovo G; Molinari E
    Obes Facts; 2022; 15(1):1-18. PubMed ID: 34818229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intragastric Balloon as Bridging Therapy Prior to Bariatric Surgery for Patients with Severe Obesity (BMI ≥ 50 kg/m
    Loo JH; Lim YH; Seah HL; Chong AZQ; Tay KV
    Obes Surg; 2022 Feb; 32(2):489-502. PubMed ID: 34787766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the safety of intragastric balloon: An analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program.
    Dang JT; Switzer NJ; Sun WYL; Raghavji F; Birch DW; Karmali S
    Surg Obes Relat Dis; 2018 Sep; 14(9):1340-1347. PubMed ID: 29934235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease: Evidence and perspectives.
    Salomone F; Sharaiha RZ; Boškoski I
    Liver Int; 2020 Jun; 40(6):1262-1268. PubMed ID: 32181573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Intragastric Balloons in the Markers of Metabolic Dysfunction-associated Fatty Liver Disease: Results from Meta-analyses.
    Zou ZY; Zeng J; Ren TY; Shi YW; Yang RX; Fan JG
    J Clin Transl Hepatol; 2021 Jun; 9(3):353-363. PubMed ID: 34221921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluid-filled intragastric balloons are an effective and safe weight loss option across BMI and age ranges.
    Marrero Torres RJ; Gregory F; Micames CG
    Surg Endosc; 2022 Jul; 36(7):5160-5166. PubMed ID: 34845556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intragastric balloon outcomes in super-obesity: a 16-year city center hospital series.
    Ashrafian H; Monnich M; Braby TS; Smellie J; Bonanomi G; Efthimiou E
    Surg Obes Relat Dis; 2018 Nov; 14(11):1691-1699. PubMed ID: 30193905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients.
    Ricci G; Bersani G; Rossi A; Pigò F; De Fabritiis G; Alvisi V
    Obes Surg; 2008 Nov; 18(11):1438-42. PubMed ID: 18369681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intragastric Balloon Significantly Improves Metabolic Parameters at 6 Months: a Meta-Analysis.
    Shah RH; Vedantam S; Kumar S; Amin S; Pearlman M; Bhalla S
    Obes Surg; 2023 Mar; 33(3):725-732. PubMed ID: 36633759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.